1.50 USD
▼-0.04-2.60%
盘后 1.68 0.00%
2026-09-16
市值
$866.43K
市盈率
—
EPS
-4.89
股息率
—
52 周区间
1.43 – 16.40
成交量
376.45K
Beta
2.08
目标价
—
52W 低 1.4352W 高 16.40
价格走势
公司简介
Scinai Immunotherapeutics Ltd., together with its subsidiaries, operates as a biopharmaceutical company in Israel and internationally. It engages in the research and development of IL-17 NanoAb, a VHH-based antibody platform for the treatment of immune-mediated and inflammatory diseases, including psoriasis; and PC111, a human monoclonal antibody for the treatment of pemphigus, Steven Johnson's syndrome, and toxic epidermal necrolysis. The company also offers contract development and manufacturing organization services, such as analytical metho...